Strategies for designing and optimizing new generation vaccines
- PMID: 11905830
- DOI: 10.1038/35105075
Strategies for designing and optimizing new generation vaccines
Abstract
Although the field of immunology developed in part from the early vaccine studies of Edward Jenner, Louis Pasteur and others, vaccine development had largely become the province of virologists and other microbiologists, because the model for classic vaccines was to isolate the pathogen and prepare a killed or attenuated pathogen vaccine. Only recently has vaccinology returned to the realm of immunology, because a new understanding of immune mechanisms has allowed translation of basic discoveries into vaccine strategies.
Similar articles
-
Jump-starting the immune system: prime-boosting comes of age.Trends Immunol. 2004 Feb;25(2):98-104. doi: 10.1016/j.it.2003.11.009. Trends Immunol. 2004. PMID: 15102369 Review.
-
Strategies for optimizing targeting and delivery of mucosal HIV vaccines.Eur J Immunol. 2009 Oct;39(10):2657-69. doi: 10.1002/eji.200939269. Eur J Immunol. 2009. PMID: 19609978 Review.
-
Contemporary approaches to designing and evaluating vaccines against Chlamydia.Expert Rev Vaccines. 2003 Feb;2(1):129-46. doi: 10.1586/14760584.2.1.129. Expert Rev Vaccines. 2003. PMID: 12901604 Review.
-
[Importance of progress achieved in fundamental biomedical sciences, especially in immunology, for the design of new vaccines].Schweiz Med Wochenschr. 1996 Jul 9;126(27-28):1208-9. Schweiz Med Wochenschr. 1996. PMID: 8766631 French.
-
New generation of mucosal adjuvants for the induction of protective immunity.Rev Med Virol. 2003 Sep-Oct;13(5):293-310. doi: 10.1002/rmv.398. Rev Med Virol. 2003. PMID: 12931340 Review.
Cited by
-
Challenges and Opportunities in the Process Development of Chimeric Vaccines.Vaccines (Basel). 2023 Dec 8;11(12):1828. doi: 10.3390/vaccines11121828. Vaccines (Basel). 2023. PMID: 38140232 Free PMC article. Review.
-
HLA-DR: molecular insights and vaccine design.Curr Pharm Des. 2009;15(28):3249-61. doi: 10.2174/138161209789105171. Curr Pharm Des. 2009. PMID: 19860674 Free PMC article. Review.
-
The prediction of T- and B-combined epitope and tertiary structure of the Eg95 antigen of Echinococcus granulosus.Exp Ther Med. 2013 Sep;6(3):657-662. doi: 10.3892/etm.2013.1187. Epub 2013 Jun 28. Exp Ther Med. 2013. PMID: 24137242 Free PMC article.
-
Cancer vaccine strategies: translation from mice to human clinical trials.Cancer Immunol Immunother. 2018 Dec;67(12):1863-1869. doi: 10.1007/s00262-017-2084-x. Epub 2017 Nov 15. Cancer Immunol Immunother. 2018. PMID: 29143114 Free PMC article. Review.
-
Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model.Virol Sin. 2012 Oct;27(5):286-91. doi: 10.1007/s12250-012-3258-5. Epub 2012 Sep 21. Virol Sin. 2012. PMID: 23001482 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical